
ETON
Healthcare · Drug Manufacturers - Specialty & Generic · $1.84B market cap
$63.93+2.48 (+4.0%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +65.9% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | 0.34 | 1.06 | +211.8% |
| Aug 13, 2026 | After the close | 0.11 | 0.35 | +218.2% |
| May 14, 2026 | After the close | 0.14 | 0.14 | 0.0% |
| Mar 12, 2026 | Time not confirmed | 0.18 | 0.19 | +5.6% |
| Nov 6, 2025 | After the close | 0.16 | 0.04 | -75.0% |
| Aug 7, 2025 | After the close | -0.01 | -0.10 | -900.0% |
| May 13, 2025 | After the close | 0.05 | -0.06 | -220.0% |
| Mar 18, 2025 | Time not confirmed | -0.00 | -0.02 | -506.1% |
| Nov 12, 2024 | After the close | -0.01 | 0.02 | +300.0% |
| Aug 8, 2024 | After the close | -0.07 | -0.12 | -71.4% |
| May 9, 2024 | After the close | -0.07 | -0.03 | +57.1% |
| Mar 14, 2024 | After the close | -0.04 | -0.09 | -125.0% |
| Nov 9, 2023 | After the close | -0.10 |
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate…
| -0.02 |
| +80.0% |
| Aug 10, 2023 | After the close | -0.09 | 0.18 | +300.0% |
| May 11, 2023 | After the close | -0.14 | -0.10 | +28.6% |
| Mar 16, 2023 | After the close | 0.01 | 0.04 | +300.0% |
| Nov 10, 2022 | After the close | -0.15 | -0.12 | +20.0% |
| Aug 11, 2022 | After the close | 0.03 | -0.06 | -300.0% |
| May 12, 2022 | After the close | -0.08 | -0.21 | -162.5% |
| Mar 16, 2022 | After the close | 0.19 | 0.04 | -78.9% |
| Nov 15, 2021 | After the close | -0.13 | -0.24 | -84.6% |
| Aug 16, 2021 | After the close | -0.14 | -0.10 | +28.6% |
| May 13, 2021 | After the close | 0.19 | 0.19 | 0.0% |
| Mar 16, 2021 | After the close | -0.26 | -0.32 | -23.1% |
| Nov 12, 2020 | After the close | -0.25 | -0.31 | -24.0% |
| Aug 12, 2020 | After the close | -0.26 | -0.23 | +11.5% |
| May 14, 2020 | After the close | -0.23 | -0.50 | -117.4% |
| Mar 5, 2020 | After the close | -0.26 | -0.15 | +42.3% |
| Nov 14, 2019 | After the close | -0.24 | -0.28 | -16.7% |
| Aug 6, 2019 | After the close | -0.28 | -0.18 | +35.7% |
| May 7, 2019 | After the close | — | -0.42 | — |
| Mar 25, 2019 | Before the open | — | -1.48 | — |
| Oct 18, 2018 | Time not confirmed | — | -0.53 | — |
| Aug 10, 2018 | Time not confirmed | — | -0.23 | — |